Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

805130

Sigma-Aldrich

PLGA microspheres

2 μm average diameter

Synonym(s):

Degradex® PLGA, PLGA Nanoparticles

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
(C3H4O2)x(C2H2O2)y
UNSPSC Code:
12162002
NACRES:
NA.23

form

powder

Quality Level

100

average diameter

2 μm

mp

~50 °C

density

1.3 g/cm3

storage temp.

−20°C

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

To re-constitute:
  • Remove the product from freezer.
  • Wait until temperature rises to the ambient temperature.
  • Add DI water or buffer to the container.
  • Vortex and sonicate for 5 minutes to ensure the microspheres are well suspended.

Application

Plain PLGA particles for testing system compatibility in drug delivery research. Particles can be used as carriers by attaching drug or biological/chemical entities to particle surface. PLGA particles are used for controlled release, sustained release and targeted drug delivery.

Legal Information

Degradex is a registered trademark of Phosphorex, Inc.

related product

Product No.
Description
Pricing

911593

NanoFabTx™ microfluidic - nano, device kit for synthesis of 100-200 nm nanoparticles and liposomes

911860

NanoFabTx™ microfluidic - micro, device kit for synthesis of 1-5 μm particles

911879

NanoFabTx™ microfluidic - micro, device kit for synthesis of 10-30 μm particles

909637

NanoFabTx™ PLGA-nano, for synthesis of 100 and 200 nm particles

912212

NanoFabTx™ PLGA-micro, for synthesis of 10-30 um particles

912220

NanoFabTx™ PLGA-micro, for synthesis of 1-5 μm particles

920436

NanoFabTx™ PEG-PLA drug formulation screening kit, for synthesis of PEGylated nanoparticles

915408

NanoFabTx™ PEGylated nanoparticle formulation screening kit

917796

NanoFabTx™ PEG-PLGA drug formulation screening kit, for synthesis of PEGylated nanoparticles

918881

NanoFabTx™ PEG-PCL drug formulation screening kit, for synthesis of PEGylated nanoparticles

918075

NanoFabTx™ PLA-nano, for synthesis of 100 and 200 nm particles

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCW1192
MKCV2291
MKCS9779
MKCP6678
MKCL7742

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Polymeric Antioxidants for Therapeutic Modalities

Polymeric antioxidants show promise in drug delivery with superior bioavailability and antioxidant potential.

Polymeric Antioxidants for Therapeutic Modalities

Polymeric antioxidants show promise in drug delivery with superior bioavailability and antioxidant potential.

Polymeric Antioxidants for Therapeutic Modalities

Polymeric antioxidants show promise in drug delivery with superior bioavailability and antioxidant potential.

Polymeric Antioxidants for Therapeutic Modalities

Polymeric antioxidants show promise in drug delivery with superior bioavailability and antioxidant potential.

See All

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service